Bellicum Pharmaceuticals (NASDAQ: BLCM) has been in continuous long-term downtrend since IPO. Stock price has been showing signs of a bottom (starting Aug 2019 to current) and with very successful … [Read more...] about BLCM #VolatilityWatch
Sangamo Therapeutics Inc.(Nasdaq: SGMO) – Doom Or Gloom Scenario
Recent data release may have changed SGMO's future outlook. Sangamo's long-term chart suggests a potential pullback to $4 is a possibility, but that was before a recent data release by the company … [Read more...] about Sangamo Therapeutics Inc.(Nasdaq: SGMO) – Doom Or Gloom Scenario
Biopharma Stock Watch May 13th-17th
The trade talks between the U.S. and Chinese officials have come and gone leaving no trade deal in place. While U.S markets were not rocked as hard as Asia's it was a still a relatively bloody week. … [Read more...] about Biopharma Stock Watch May 13th-17th
Nabriva's Hype It has been decades since the US has seen a new novel treatment in the antibiotics arena, creating positive sentiment surrounding the approval of Nabriva's Contepo (fosfomycin). … [Read more...] about Pdufa Watch
You must be logged in to post a comment.